Harnessing nanomedicine to potentiate the chemo-immuno-2 therapeutic effects of doxorubicin and alendronate co-encapsu-3 lated in pegylated liposomes

John Maher

Harnessing nanomedicine to potentiate the chemo-immuno-2 therapeutic effects of doxorubicin and alendronate co-encapsu-3 lated in pegylated liposomes

Comprehensive Cancer Centre

Research output: Contribution to journal › Article › peer-review

103 Downloads (Pure)

Original language	English
Journal	Pharmaceutics
Publication status	Accepted/In press - 3 Nov 2023

Access to Document

pharmaceutics-2673276-31-10-2023Accepted author manuscript, 2.57 MBLicence: CC BY

Cite this

@article{868c19dfde0d45c6b4dbe164bd049be0,

title = "Harnessing nanomedicine to potentiate the chemo-immuno-2 therapeutic effects of doxorubicin and alendronate co-encapsu-3 lated in pegylated liposomes",

author = "John Maher",

year = "2023",

month = nov,

day = "3",

language = "English",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute",

}